Upcoming MDPI Conferences (1)
16–30 March 2023 3rd International Electronic Conference on Cancers: New Targets for Cancer Therapies (IECC 2023)
We are pleased to announce the 3rd International Electronic Conference on Cancers: New Targets for Cancer Therapies (IECC 2023). The conference is organized by the MDPI open-access journal Cancers ( IF 6.575) and will be held online from 16–30 March 2023.
Abstract Submission Deadline: 5th January 2023
Notification of Acceptance Deadline: 31st January 2023
Full Paper Submission Deadline: 13th February 2023
Conference Open: 16–30 March 2023
Opportunities for new therapeutic targets have expanded tremendously. In recent years, cancer genomics has expanded our view of cancer vulnerabilities, new technologies have changed the paradigm of what can be successfully targeted, and new immunotherapy targets continue to emerge at a rapid pace. This conference aims to promote and advance the coordinated progress in oncology research to foster the development of innovative therapeutic strategies. It will bring together experts in basic, translational, and clinical research to discuss the current research and opportunities as well as the obstacles that lie ahead in the field.
The focus of this conference is the translation of recent discoveries into new therapeutic targets for cancer therapies. Topics of interest include but are not limited to the following:
- Translational cancer genomics and epigenomics;
- Emerging immunotherapy targets;
- Overcoming therapeutic hurdles in resistance and undruggable proteins.
There will be five specific sessions:
Session 1: Genome-Wide Approaches for Target Identification;
Session 2: Targeting Metastasis;
Session 3: Novel Immunotherapy Targets;
Session 4: Novel Approaches for ‘Undruggable’ Targets;
Session 5: Overcoming Therapeutic Resistance.
Participants will have the opportunity to examine, explore, and critically engage with issues and advances in these areas. We hope to facilitate discussions and exchange within the community.
This event will be a solely online proceeding, which allows for participation from around the world with no concerns regarding travel and related expenditures. This type of conference is particularly appropriate and useful, as cancer-related research is progressing rapidly. An electronic conference provides a platform for rapid and direct exchanges about the latest research findings and novel ideas. Attendance and participation in this online conference is completely free.
The accepted conference proceedings papers and presentations will be available online for discussion on 16–30 March 2023 and will be published in the journal Medical Sciences Forum. All participants are encouraged to submit an extended full manuscript to the Cancers conference Special Issue "IECC2023: New Targets for Cancer Therapies" with a 20% discount on the APC. Cancers (ISSN 2072-6694; IF 6.575) is a peer-reviewed and open access journal of oncology that is published semimonthly online by MDPI.
We hope that the community will share our enthusiasm and help to make this conference a success.
Dr. Carlos S. Moreno
The Chair of the 3rd International Electronic Conference on Cancers: New Targets for Cancer Therapies
JCM announces selected third-party conferences. In case you would like to announce your own event on the JCM website, please fill out the following form to apply for the announcement of a conference or other academic event (seminar, workshop).
Upcoming Partner Conferences (1)
26–29 April 2023 56th Annual Meeting of the Association for European Paediatric and Congenital Cardiology
It is our pleasure to welcome you to the 56th Annual Meeting of the Association for European Paediatric and Congenital Cardiology, to be held in Dublin, Ireland, between April 26 and 29, 2023. The meeting is hosted by the local organising committee from Children’s Health Ireland, Dublin, and Royal Belfast Hospital for Sick Children, Belfast, Northern Ireland.
We are committed to offering an exciting annual meeting. This is a remarkable opportunity for us on the island of Ireland, and we know that the meeting will be a very positive experience for everyone involved. Both centres and the All-Island Congenital Heart Disease Network will do everything possible to make this a memorable meeting. We look forward to hosting an academically stimulating conference with exceptional speakers on important topics in congenital heart disease. We have established a local scientific committee to work closely with the scientific advisory group to optimise the quality of the content and to make the meeting as relevant, high-impact, and stimulating as possible.